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The subject of vasculitis i s  a broad and de- 
tailed one, including many varied etiologies, 
clinical syndromes, classification systems, 
and pathological descriptions. The varying 
syndromes which have often been separated 
clinically are most likely manifestations of the 
same pathogenetic process immune-complex 
disease. In this paper, we wil l  review 6 aspects 
of vasculitis: (1) historical perspectives and 
classifications, (2) cl inical features, ( 3 )  
etiological or predisposing factors, (4) 
pathogenesis, (5) relation of anatomical and 
nonimmunological factors to clinical pres- 
entation, and (6) evaluation and treatment. 
We wil l  attempt to unify the various entities 
based on their similarities. 
Historical Perspectives 
and Classification 
The earliest classification of vasculitis was 
that of Zeek in 1952; who reviewed the litera- 
turefrom 1886 to 1952. During this period the 
literature concentrated on pathological de- 
scriptions and speculations as to etiologies, 
with lues, bacterial and viral infections, and 
various toxins being considered as possible 
causes. The terms vasculitis, periarteritis 
nodosa, and arteritis were used synonym- 
ously during this period, with periarteritis 
being the most commonly used term. 
By the early 1950‘s the term periarteritis 
nodosa was indeed a broad one, encompass- 
ing necrotizing or hypersensitivity angiitis, 
po I y arter i t is, tem pora I arter i t i s, Wege ne rf s 
granulomatosis, the allergic vasculitis of 
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Churg and Strauss, and others. Zeek attemp- 
ted to delineate 5 specific clinicopathological 
entities: hypersensitivity angiitis, allergic 
granulomatous vasculitis, rheumatic arteritis, 
periarteritis nodosa and temporal arteritis. She 
proposed that these entities be used in place 
of the then more general term periarteritis 
nodosa. However, the literature subsequent 
to her review has continued to propose multi- 
ple and varied classifications. 
A significant problem in approaching the 
topic of vasculitis remains the student’s c o p  
ing with the numerous classifications. The dif- 
ficulty was first summarized in 1802 by 
Heberden (requoted by Copeman),2 who 
stated: “There is a great variety of cutaneous 
disorders. Several of the appearances here 
mentioned have been distinguished among 
the ancient physicians by peculiar names: 
there i s  a great difficulty, though happily not 
much use, in ascertaining the appearances to 
which these names were appropriated; for 
this reason the ancient divisions and titles are 
very little regarded by the moderns. Many 
morbid appearances of the skin are judged to 
be proofs of a diseased constitution rather 
than merely local disorders of the part which 
i s  afflicted with them.” This 1 50-year-old 
statement i s  still valid today. Briefly there are 
“many rashes; unnecessary names; and sys- 
temic significance.”* 
Classifications have been based on the his- 
tological patterns of involvement, the type of 
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vessel involved, and the extent of clinical 
involvement-cutaneous, systemic or both? 
We believe that ideally a classification of vas- 
culitis should separate disease entities accord- 
ing to differing pathogenic mechanisms, 
should provide some information about clini- 
cal features and presentation, and should 
separate diseases with varying prognoses. Un- 
fortunately, no present system includes all of 
these features. Therefore, we think that the 
best classification of vasculitis limit the defini- 
tion to those condiiions which are charac- 
terized pathologically by infiltration with 
polymorphonuclear leukocytes, with frag- 
mentation of nuclei, involving either small or 
large vessels. The terms vasculitis and angiitis 
should be used interchangeably. This defini- 
tion wil l include the entities of hypersensitiv- 
ity or necrotizing angiitis, anaphylactoid pur- 
pu ra pu rpu ra), 
rheumatoid vasculitis, and periarteritis 
nodosa. The significant feature of all t hae  
entities i s  that they are characterized histolog- 
ically by fibrinoid necrosis of vessel wall and 
leukocytoclasis (or fragmentation of neutro- 
phils with nuclear dust):’ The problem of clas- 
sification is  thereby eliminated, thus enabling 
us to approach a group of diseases bearing 
many names but which have similar clinical 
presentation and pathogenic mechanisms. 
(Sc h on lei n- Henoc h 
Clinical Features 
The clinical manifestations of vasculitis 
may be separated into cutaneous (Table 1 )  
and systemic (Table 2) groups. 
In 1964 Winkelmann and Ditto4 analyzed 
38 cases of angiitis defined by leukocytoclasis 
and fibrinoid necrosis pathologically. The 
cutaneous lesions were urticaria, petechiae, 
papules, plaques, nodules, bullae and necro- 
tic ulceration. No single type of lesion pre- 
dominated. Usually there was more than one 
type of lesion present. A universal finding was 
that of hemorrhage into the skin. Livedo re- 
ticularis was occasionally present. There was 
preferential involvement of dependent pol- 
tions of the body, but lesions did occur 
elsewhere, including the oral mucosa. Al- 
though cutaneous vasculitis usually i s  seen 
with varied lesions, one type may predoml- 
nate. Soter, Austen, and Gigli5 reported a 
series of 8 patients in whom chronic urticaria 
was the only sign of leukocytoclastic angiitis. 
The urticaria in these patients was atypical in 
that i t  was of long duration-up to 72 
hours-and associated with an elevated Wes- 
tergren erythrocyte sedimentation rate (ESR). 
Seven of 8 cases were accompanied by ar- 
thralgias. There was a low total hemolytic 
complement in 2 of the 8 patients. The authors 
conclude that urticaria associated with an 
elevated erythrocyte sedimentation rate may 
be suggestive of vasculitis. However, the du- 
ration of the urticaria may be a more valuable 
sign of vasculitis than an elevated erythrocyte 
sedimentation rate (JPC unpublished observa- 
tion). 
Systemic involvement in necrotizing an- 
giitis is  quite common:’*6-s In Winkelmann’s 
series only a small percentage of patients had 
disease l imi ted to the s k i n s 4  I n  1965 
McCombs9 reported a series of 72 patients 
with confirmed pathological leukocytoclastic 
vasc~l i t is .~ The data of both Winkelmann and 
McCombs are presented in Table 2. 
Aithralgias occurred in approximately 1 / 3  
of the patients while arthritis was less com- 
mon. GI bleeding occurred in approximately 
10-1 5% in each series. Renal involvement as 
manifested by hematuria was common, al- 
though azoternia was less frequent. Car- 
d iores pi rator y involvement was infrequent. 
The nervous system was more commonly in- 
volved in McCombs series. The presence of 
systemic involvement and the type of organ 
involved i s  similar to that seen in Henoch- 
Schonlein purpura characterized by purpuric 
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Table 2. Systemic Involvement in 
Leukocytoclastic Angiitis 
(Number of Cases) 
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* Winkelmann, R. K. and Ditto, W. B., 19644 
t McCombs, R. P., 19659 
vasculitis with hematuria and GI bleed- 
ing.'O*ll It i s  also similar to polyarteritis which 
commonly i s  seen with neuropathy, renal dis- 
ease, hypertension, abdominal pain, arthral- 
gia, fever and weight IOSS.'~-'~ Although this 
disease less frequently produces cutaneous 
manifestations, the lesions are similar and 
forms l imi ted to  the skin e x i ~ t . ' ~ > ' ~ * ' ~  
Rheumatoid vasculitis also has similar 
cutaneous manifestations and may have seri- 
ous systemic invol vement?? 17*1H 
Vasculitis has generally been reported to 
have a grave prognosis, particularly polyar- 
teritis, and rheumatoid vasculitis. However, 
all of the aforementioned clinical syndromes 
have varied prognoses, depending mainly on 
the extent and type of systemic involve- 
ment.4,10*12-17,19 Cases of idiopathic cutane- 
ous vasculitis without significant systemic in- 
volvement and with spontaneous resolution 
are frequent. 
Predisposing Factors 
The etiological or predisposing factors in- 
volved i n  vasculitis are listed in Table 3, 
which represents the work of Winkelmann4 
(series l), and McCombs9 (series 2). The pres- 
Table 3. Etiology of "Vasculitis"* 
Series 
I (38)* II (72) t  
Infection 3-6 22 
Drugs 20  26 
Collagen-vascular 3 12 
Lymphoproliferative 0 5 
Unknown 12 33 
* Winkelmann, R. K. and Ditto, W. B., 19644 
t McCombs, R. P., 19659 
ence of infection, particularly of the upper 
respiratory tract, before development of vas- 
culitis, was common, as was drug ingestion. 
However, an overlap occurred since many 
patients with suspected infections had had 
medication. Vasculitis in association with 
rheumatoid arthritis and lupus erythematosus 
was also seen. Also, McCombs had 5 patients 
with tumors. Henoch-Schonlein purpura is  
commonly associated with antecedent infec- 
t ion or drug Polyarteritis 
nodosa has been found to be commonly re- 
lated to immune complexes formed by 
hepatitis-associated antigen and anti bodyF1 
and it has been associated wi th  other 
collagen-vascular diseases and with am- 
p hetam i ne abuse." 
Pathogenesis 
The association of vasculitis with autoim 
mune diseases prompted investigation intc 
the immune system as a possible etiologica 
factor. Also, the association of vasculitis wit1 
previous or coexistent infection promptec 
studies of bacterial antigens in the lesion! 
Most investigators have viewed angiitis as 
Type I l l  reaction (or immune complex disoi 
der)?0*22-27 P a r i ~ h ~ " ~ '  in 1971 presented 
series of controlled studies of patients wit 
vasculitis, in whom the serum and skin we1 
examined for immunoglobulins, bacterii 
antigens, complement (plC) and C-reactib 
protein. Immunoglobulins were in cutaneoi 
vessel walls in only 50% of the patients ar 
10% of controls. Only skin of patients w i  
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vasculitis demonstrated complement in the 
lesions. C-reactive protein, streptococcal, 
candidal, and mycobacterial antigens were 
rarely found in association with vasculitis. 
lmmunofluorescent staining of vasculitic le- 
sions for soluble bacterial antigens was insig- 
nificant. A higher incidence of rheumatoid 
factor, anti-lgG, and immunoconglutinin was 
found in the sera of patients with cutaneous 
angiitis. 
Parish concluded that there was indirect 
evidence that cutaneous vasculitis was 
caused by immune complexes, but that there 
was no evidence of bacterial antigens being 
important etiologically. In further experi- 
ments he examined sera of patients with and 
without vasculitis for antibodies to protein 
and polysaccharide of streptococci and 
staphylococci and found that the antibody- 
antigen complexes were no different in their 
ability to fix complement or release enzymes 
from white blood cells in vitro in patients with 
or without vasculitis. Therefore, he concluded 
that the properties of serum antibodies in con- 
valescent antisera cannot determine suscep- 
tibility to vasculitis. He also concluded that 
bacterial antigens may play a direct role in 
potentiating immune-complex induced vas- 
cular damage via a Shwartzman reaction (di- 
rect effect of bacterial toxins which may cause 
fibrin deposition). These studies suggest that 
bacterial-antigen-antibody complexes are not 
of etiological significance, but that bacterial 
antigens may potentiate damage of other 
antigens-antibody complexes. This may ex- 
plain the vasculitis which clinically seems to 
follow infection. 
The similar natureofthe inflammatory reac- 
tion in vasculitis to the experimental Arthus 
reaction (immune-complex disorder) in ani- 
mals prompted investigations of  the 
pathogenetic role of immune complexes. 
Much of the initial work done in the late 60's 
has been well summarized by Copeman.2 
In some series serum immunoglobulins are 
often nonspecifical ly elevated, but the levels 
of immunoglobulin may reflect underlying 
disease." The amount of immunoglobulin 
may be quite small in the serum with the 
majority being in tissue; this makes the total 
serum immunoglobulin level of little value in 
investigations of angiitis. Early studies at the 
Mayo C l i n i ~ ~ ~ , ~ ~  and in England33 dernon- 
strated immunoglobulins and complement in 
the cutaneous lesions of patients with vas- 
culitis. This i s  nonspecific etiologic evidence, 
as immunoglobulins may deposit secondarily 
in damaged ti~sue.3~ However, the clinical 
distribution of the vasculitic lesions and their 
production by vasoactive amines suggests a 
role for circulating immune complexes.26 The 
leukocytoclasis suggests that the Shwartzman 
reaction may be pathogenetically impor- 
tantPO 
M c D ~ f f i e ~ ~  presented a series of 7 patients 
with cutaneous angiitis. The serum comple- 
ment was depressed in all cases. In patients in 
whom the vasculitis disappeared, the com- 
plement levels returned to or toward normal. 
These findings are suggestive of the impor- 
tance of immune complexes in vasculitis. 
However, subsequent studies failed to reveal 
immunoglobulins in a significant proportion 
of cases of acute cutaneous a n g i i t i ~ . 2 ~ - ~ ~  This 
led to confusion, although the process was 
still believed by many to represent an Arthus 
reaction. 
In 1971 Cream and  associate^^^ studied the 
experimental Arthus reaction by immuno- 
fluorescence. They attempted to define the 
appearance and disappearance of immuno- 
globulin and complement in the lesions. After 
sensitization to ovalbumin, guinea pigs were 
given an intradermal injection of ovalbumin 
and then killed at varying times. The skin test 
site was then examined for immunoglobulin 
and complement. Controls were from normal 
skin in test animals and from unsensitized 
animals' skin test sites. The controls showed 
no immunofluorescence. 
Clinically, the skin test sites showed ery- 
thema and induration within 10 minutes and 
hemorrhage within 1-2 hours. The lesion was 
most intense at 4 hours and was resolving at 
18 hours. Histologically at 20 minutes there 
was vasodilation and margination of 
polymorphonuclear cells; at 1 hour there was 
cell migration through the vessel walls; at 4 
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hours there was necrosisof many vessels. By 8 
hours the perivascular nature of the infiltrate 
was less evident and mononuclear cells were 
seen, and by 18 hours on ly  a patchy 
mononuclear infiltrate remained. Immuno- 
fluorescence appeared at 20 minutes and was 
most intense at4 hours with granulardeposits. 
At 8 hours only complement remained and by 
18 hours no immunofluorescence was found. 
Although this is  an experimental animal 
study, the applicability to humans is poten- 
tially significant. It can be easily recognized 
that if an older lesion is studied by biopsy, 
immunofluorescence may not be demon- 
strated (possibly due to destruction by en- 
zymes). Thus in both clinical studies and prac- 
tice the failure to find immunoglobulin is  not 
significant unless the lesion examined by 
biopsy i s  known to be an early lesion. 
Cream3' evaluated 32 patients with various 
cutaneous vasculitides for anticomplemen- 
tary sera. The patient's serum was mixed with 
complement and then sensitized red blood 
cells were added. Anticomplementary activ- 
ity was considered to be present if the red 
blood cells were not hemolyzed. The sera 
were heated to 56°C and then retested. Elev- 
en patients had anticomplementary activity 
and in all cases the activity was inhibited or 
reduced by heating. Five of the patients with 
positive results had cryogiobulinemia. How- 
ever, not all those with cryoglobulins had an- 
ticomplementary sera. There are 2 possible 
explanations for these results: (1) the presence 
of immune complexes capable of fixing com- 
plement or (2) the presence of inhibitors such 
asC1 esterase inhibitor or C6 inhibitors, each 
of these mechanisms being heat labile. This 
study shows that patients with angiitis may 
have circulating immune complexes which 
can fix complement in vitro. In vivo, their 
precipitation might initiate the complement 
cascade. Although indirect, this evidence 
strongly favors an Arthus type reaction for the 
pathogenesis of cutaneous angiitis. 
Subsequent studies on the sera of patients 
with vasculitis have demonstrated C l q  pre- 
ciptins, which measure the presence of serum 
immune c ~ m p l e x e s P * ~ ~ ~  Additional evidence 
of immune complex involvement in cutane- 
ous angiitis has been reported by S a m ~ . ~ ~  Skin 
biopsies of uninvolved and involved skin in 
13  patients with necrotizing vasculitis were 
examined for the presence of immunoglobu- 
lins and complement components. Ten pa- 
tients had positive staining in involved skin, 
and 7 patients had staining of the uninvolved 
skin with complement components of the 
classical pathway. The authors thought that 
this represented evidence of circulating im- 
mune complexes which were depositing in 
clinically normal skin. Their biopsies, how- 
ever, were generally in close proximity to dis- 
eased areas. 
Braverman and Yenz3 were able to demon- 
strate immune complexes in vasculitic lesions 
induced by histamine in uninvolved normal 
skin of patients with leukocytoclastic angiitis. 
The histamine-induced lesions contained typ- 
ical histological changes of vasculitis. Also on 
electron microscopy, immune complexes 
were present in nonmanipulated normal skin 
of patients h i t h  vasculitis but histologic 
changes were absent. The investigators be- 
lieved that these findings indicate that im- 
mune complexes are deposited in vessels be- 
fore tissue damage ensues and suggested that 
since immunofluorescence is frequently ab- 
sent in older lesions histamine injection may 
aid in the demonstration of immunofluores- 
cence in vasculitis. 
Finally, Jones et alP' reported a case of 
vasculitis in which injection of a patient's 
serum intradermally produced clinical le- 
sions of vasculitis. Fractionation of the serum 
showed that this property was associated 
with IgG, and the authors concluded that 
there was an immune complex present in this 
patient's serum. This i s  a clinical example of 
an Arthus reaction. 
These studies have dealt mainly with pa- 
tients with cutaneous vasculitis. Polyarteritis, 
a primary systemic vasculitis, may have a 
similar pathogenesis12*14~21*2z,4z*43 since 
studies have shown a high correlation with 
Australia antigen. Recently Trepo and his 
group44 have studied the role of circulating 
complexes of hepatitis B antigedantibody in 
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the pathogenesis of vasculitic lesions of 
polyarteritis. The patients in this study were 
divided according to disease activity, and 
sera were obtained for hepatitis-associated 
antigen and hepatitis-associated antibody 
measurements. Sixty-five per cent of the 
samples contained hepatitis-assoc iated anti- 
gen. Eight cases were found with antibody 
only. 
The titers of antigen did not correlate with 
disease activity but clinical improvement 
correlated with disappearance of hepatitis- 
associated antigen and appearance of a low 
level of HB antibody. Seven patients with 
antibody only were in the quiescent group (4) 
or were in remission (3). Hepatitis-associated 
antigen (HBAg)-Hepatitis-associated anti- 
body (HBAb) immune complexes are not 
able to induce liver damage in HBAg 
hepatitis, thus, the mechanisms of liver tox- 
icity may be a cell-mediated phenomenon. 
However, polyarteritis associated wi th  
HBAg-HBAb immune complexes appears to 
be an Arthus (Type Ill) hypersensitivity reac- 
tion. The presence of immune complexes 
and their relationship to polyarteritis is  curi- 
ous because immune complexes should not 
passively deposit in larger vessels with fast 
flow, but rather should be deposited in smal- 
ler cutaneous 
Further studies by Sergent et aI.l4 have 
suggested that the vasculitis occurring with 
HBAg is not always a true polyarteritis. They 
found that only the presence of subclinical 
liver disease could separate those patients 
with hepatitis and necrotizing angiitis from 
patients with angiitis only. Also they recon- 
firmed the notion that the hepatitis and vas- 
culitis were not mechanistically the 
~ a m e . ' ~ , ~  In an additional study, they inves- 
tigated 27 patients with hepatitis B antigen 
and found a strikingly high level of cryopro- 
teins which had biological properties as- 
sociated with immune c0mplexes.4~ Several 
of their patients with cryoproteins had man- 
ifestations of serum sickness. The authors 
suggested that the investigation of cryopro- 
teins in patients with hepatitis may be of clin- 
ical and pathogenic importance. 
Duffy et a1.12 divided patients with HBAg 
hepatitis into 2 groups: (1) those with trans- 
ient polyarthralgias and rashes (generally 
more benign disease), and (2) those with vas- 
culitis. However, no skin biopsies were done 
despite the presence of urticaria1 and pur- 
puric lesions in their first group. Probably 
their groups merge as those in the studies by 
Sergent et aI.l4 
Similar studies on rheumatoid vasculitis 
suggest that it i s  a disease of immune com- 
plexes,S.18 since immune complexes are de- 
tectable in the sera and synovial fluids of pa- 
tients with rheumatoid arthritis (RA).'8 It has 
also been reported that cutaneous vessel 
immune deposits occur frequently in 
seropositive patients with rheumatoid arthri- 
tis, and that there was a slightly higher fre- 
quency of immune deposits in those patients 
with clinical vasculitis? 
It is apparent from these studies that the 
majority of indirect and direct evidence 
suggests that necrotizing angiitis, Henoch- 
Schonlein purpura, polyarteritis nodosa, and 
rheumatoid vasculitis are immune complex 
disorders or forms of Type Ill hypersensitivity. 
Relationship of Anatomic and 
Nonimmunological Factors to 
Clinical Presentation 
Two patterns of disease are found clini- 
cally: (1) a small punctate pattern and (2) a 
larger or reticulate pattern as in livedo, re- 
ticularis.2*20 Both patterns have propensity for 
involvement of the legs.2O The interrelation of 
anatomical and nonimmunological factors 
responsible for these manifestations has been 
outlined by Copeman.20 Some are well 
worked out as being mechanistically impor- 
tant, others are only of hypothetical impor- 
tance. The clinical presentations depend on 
the blood vessel affected (arterioles or ven- 
ules) and their size and proximity to the skin. 
The nonimmunological factors involved are: 
(1) outflow blockade by red blood cells, 
platelets, or fibrin; (2) viscosity of blood; and 
(3) pressure-internal or These 3 
factors are interrelated. 
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History and physical examination 
Complete blood count and platelet count 
Urinalysis 
Cryoglobu I ins, macroglobul i ns 
Hepatitis-associated antigen-antibody 
Coagulation and Fibrinolysis 
Histology 
Complement studies 
Rule out infection (endocarditis) 
Immunofluorescence (optional) 
Studies of altered fibrinolysis have been 
done by Cunliffe et al.,47 who reported 3 pa- 
tients with vasculitis with decreased fibrinoly- 
tic activity in their blood as measured by the 
reciprocal of the eqlobul in  lysis time. Sub- 
sequent studies on additional patients have 
shown similar f i n d i n g ~ . 4 ~ . ~ ~  Also decreased 
tissue fibrinolytic activity in cutaneous lesion 
of vasculitis has been demonstrated.42,50 Thus 
the fibrinolytic system may be an important 
factor inamplifyingthedamageinitiatedbythe 
immune complexes. 
Other mechanisms which may be involved 
have been studied at length in experimental 
animals as reported by C0chrane.3~ These data 
have beensummarized bySamsz6 in aprevious 
review and wil l not be reviewed in this paper. 
Basically, immune complexes attain a certain 
critical size causing their precipitation be- 
tween cells. This activates the complement 
cascade which leads to release of vasoactive 
amines, chemotaxis, and possible fibrinolytic 
blockade. As the inflammatory reaction prog- 
resses, necrosis and hemorrhage occur, pro- 
ducing the clinical signs of vasculitis. 
Evaluation and Treatment 
This discussion of classification, etiology 
and pathogenesis of vasculitis can be of much 
practical value when applied to evaluation 
and treatment. Based on the discussion, physi- 
cians evaluating patients with cutaneous an- 
giitis should attempt to establish whether the 
involvement i s  limited to the skin or is systemic 
in nature (Table 4). A thorough history and 
physical examination are basic to this. A 
Table 5. Treatment of Vasc ulit ir 
1. Symptomatic relief: elevation, frequent turning 
2. Correction of coagulation-fibrinolytic system abnor- 
malities: phenformin, ethylestrenol 
3 .  Blockade of immune complex deposition, comple- 
mentadvation and polymorphonuclear leukocyte ac- 
tivity: corticosteroids, cytotoxic drugs 
urinalysis is also a valuable screening tool in 
determining the presence of renal involve- 
ment. The use of invasive studies should de- 
pend on the individual case. Additional labo- 
ratory evaluation should include the coagula- 
tion and fibrinolytic tests, cryoprecipitable 
proteins, macrog lo bu I ins, and com p I ement 
activation. Other causes of similar rash, par- 
ticularly bacterial endocarditis, must be ruled 
out?' The histology of the cutaneous disease 
should be reviewed. Immunofluorescence52 
can be done on an early lesion or an induced 
I es io n F 3  
Treatment of "vascul itis" should bedi rected 
at both symptoms and etiology (Table 5). Loc- 
ally increased intravascular pressure may be 
relieved by elevation. Frequent turning also 
wil l decrease pressure on truncal lesions. Be- 
cause altered fibrinolysis and coagulation may 
perpetuate the disease long after the initiating 
event, anticoagulants have been used with 
varying success. Also, anti platelet drugs such 
as phenformin and ethylestrenol have been 
u ~ e d . 4 ~ - ~ ~  These agents also increase blood 
fibrinolytic they have been demon- 
strated to be useful and produce little tox- 
i ~ i t y . 4 ~ 3 ~ ~  Other agents used with variable suc- 
cess rates have been sulfones and nicotinic 
acid.I7 
Becausevasculitisappearsto bean immune 
complex disorder, steroids have been 
suggested as being e f f e c t i ~ e . ' ~ ~ ~ ~  S a m P  
suggests that because they appear to be effec- 
tive in another immune complexdisorder, sys- 
temic lupus erythematosus, they might have 
some benefit in the treatment of vasculitis. 
However, no controlled clinical study has 
demonstrated their usefulness in treatment of 
vasculitis and some reports have suggested 
that there i s  an unpredictable response." 
112 INTERNATIONAL JOURNAL OF DERMATOLOGY March 1978 Vol. 17 
Lastly, cytotoxic agents have been used with 
variable resp0nse.5~ 
Conclusion 
In conclusion, we believe that there are 
many similarities between the various entities 
characterized by leukocytoclastic angiitis, 
namely the clinical presentation, pathogenesis 
and relationshipto internal disease. Those per- 
forming recent studies have been unable to 
demonstrate prognostic differences based on 
clinical criteria. Treatment regimens are 
nonspecific and symptomatic. Therefore, we 
conclude that these disorders should be 
grouped underone descriptive title, cutaneous 
angiitis, until pathogenetic, prognostic or 
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Male Contraceptives 
Research in human reproduction has been stimulated in recent years by increasing 
awareness of the worldwide threat posed by unchecked population growth. Much of 
this research has been directed toward improving technics of contraception. The 
efficacy of available contraceptives for men has lagged well behind those in use by 
women. Much recent work has been aimed at correcting this deficiency through the 
development of safe, reliable and reversible technics for male contraception. 
Although optimal means are not yet available, limited clinical trials of several new 
methods have yielded encouraging results.-Brenner, W .  I., deketser, M.D., The 
Prospects fo r  New, Reversible Male Contraceptives. N. Engl. ). Med. 295: 1 1  1 1 ,  
1976. 
